Fonds Themen
Themenfonds
Themenfonds
| Abaris Biotechnology Opportunities A CHF | CHF | Aktienfonds | - | 93.97 | -0.06% | +25.16% | +39.90% | +60.77% | +132.14% |
| Abaris Biotechnology Opportunities A USD | USD | Aktienfonds | - | 103.08 | -0.01% | +19.26% | +34.60% | +55.01% | +158.61% |
| Janus Henderson Horizon Biotechnology Fund GU2 EUR | EUR | Aktienfonds | - | 34.63 | +1.26% | +15.01% | +17.39% | +52.42% | - |
| Janus Henderson Horizon Biotechnology Fund S2 EUR | EUR | Aktienfonds | - | 34.29 | +1.27% | +14.41% | +17.39% | +51.99% | - |
| Janus Henderson Horizon Biotechnology Fund IU2 EUR | EUR | Aktienfonds | - | 33.03 | +1.29% | +14.81% | +17.21% | +51.65% | +87.24% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK | SEK | Aktienfonds | - | 1'353.29 | -0.49% | +29.50% | +30.17% | +51.53% | +50.58% |
| Janus Henderson Horizon Biotechnology Fund A2 EUR | EUR | Aktienfonds | - | 32.38 | +1.28% | +14.22% | +16.77% | +50.60% | +84.92% |
| Janus Henderson Horizon Biotechnology Fund GU2 GBP | GBP | Aktienfonds | - | 35.81 | +1.36% | +12.97% | +15.78% | +49.96% | - |
| Janus Henderson Horizon Biotechnology Fund GU2 USD | USD | Aktienfonds | - | 36.11 | +1.09% | +11.24% | +16.18% | +47.09% | - |
| Janus Henderson Horizon Biotechnology Fund E2 USD | USD | Aktienfonds | - | 42.35 | +1.07% | +11.30% | +16.12% | +46.90% | +104.59% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD | USD | Aktienfonds | - | 158.46 | -0.26% | +21.54% | +24.94% | +46.57% | +74.23% |
| Janus Henderson Horizon Biotechnology Fund IU2 USD | USD | Aktienfonds | - | 40.93 | +1.09% | +11.04% | +15.95% | +46.49% | +102.02% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD | USD | Aktienfonds | - | 485.09 | -0.27% | +21.36% | +24.81% | +46.28% | +73.18% |
| Janus Henderson Horizon Biotechnology Fund H2 USD | USD | Aktienfonds | - | 40.31 | +1.08% | +10.83% | +15.80% | +46.16% | +101.05% |
| Janus Henderson Horizon Biotechnology Fund S2 USD | USD | Aktienfonds | - | 35.61 | +1.11% | +10.69% | +15.80% | +46.06% | - |
| Janus Henderson Horizon Biotechnology Fund GU2 HEUR | EUR | Aktienfonds | - | 35.09 | +1.09% | +9.90% | +15.31% | +45.97% | - |
| Janus Henderson Horizon Biotechnology Fund A2 USD | USD | Aktienfonds | - | 39.55 | +1.07% | +10.41% | +15.51% | +45.40% | +98.25% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD | USD | Aktienfonds | - | 1'068.90 | -0.27% | +20.45% | +24.18% | +44.80% | +67.96% |
| Janus Henderson Horizon Biotechnology Fund E2 HEUR | EUR | Aktienfonds | - | 36.34 | +1.08% | +10.02% | +15.29% | +44.67% | +94.96% |
| Janus Henderson Horizon Biotechnology Fund IU2 HEUR | EUR | Aktienfonds | - | 36.62 | +1.08% | +9.74% | +15.08% | +44.46% | +88.18% |
| Pictet - Biotech - Z EUR | EUR | Aktienfonds | - | 1'812.60 | -0.39% | +14.16% | +14.01% | +43.76% | - |
| Janus Henderson Horizon Biotechnology Fund H2 HEUR | EUR | Aktienfonds | - | 30.59 | +1.09% | +9.56% | +14.96% | +43.75% | +90.95% |
| Candriam Equities L Biotechnology, R - Capitalisation | EUR | Aktienfonds | - | 509.79 | +0.94% | +20.18% | +19.46% | +43.73% | +76.56% |
| Candriam Equities L Biotechnology, I - Capitalisation | EUR | Aktienfonds | - | 3'437.73 | +0.94% | +20.36% | +19.66% | +43.53% | +73.45% |
| PMG Helix Biotechnology Fund I USD | USD | Aktienfonds | - | 133.32 | +0.85% | +17.78% | +19.17% | +43.40% | +64.37% |
| PMG Helix Biotechnology Fund R USD | USD | Aktienfonds | - | 139.44 | +0.85% | +17.61% | +19.06% | +43.12% | +63.41% |
| Janus Henderson Horizon Biotechnology Fund A2 HEUR | EUR | Aktienfonds | - | 29.73 | +1.05% | +9.10% | +14.65% | +43.00% | +87.10% |
| Candriam Equities L Biotechnology, C - Capitalisation | EUR | Aktienfonds | - | 338.02 | +0.93% | +19.36% | +18.90% | +42.40% | +71.68% |
| Pictet - Biotech - I EUR | EUR | Aktienfonds | - | 1'570.48 | -0.40% | +13.32% | +13.44% | +42.35% | +82.85% |
| JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR | EUR | Aktienfonds | - | 86.76 | +0.24% | +22.92% | +23.59% | +41.70% | +33.33% |
| Franklin Biotechnology Discovery Fund - I (acc) USD | USD | Aktienfonds | - | 108.04 | +0.57% | +13.01% | +17.10% | +41.32% | +107.33% |
| Franklin Biotechnology Discovery Fund - W (acc) USD | USD | Aktienfonds | - | 33.72 | +0.57% | +12.96% | +17.08% | +41.27% | +107.00% |
| Franklin Biotechnology Discovery Fund - A (acc) HKD | HKD | Aktienfonds | - | 43.55 | +0.58% | +13.21% | +16.72% | +41.26% | +102.46% |
| Pictet - Biotech - P EUR | EUR | Aktienfonds | - | 1'276.07 | -0.41% | +12.57% | +12.94% | +41.09% | +78.02% |
| Candriam Equities L Biotechnology, R - Capitalisation | GBP | Aktienfonds | - | 564.16 | +0.57% | +18.05% | +17.95% | +41.03% | +74.85% |
| Candriam Equities L Biotechnology, I - Capitalisation | GBP | Aktienfonds | - | 5'304.85 | +0.57% | +18.24% | +18.13% | +40.85% | +71.80% |
| Franklin Biotechnology Discovery Fund - A (acc) USD | USD | Aktienfonds | - | 66.62 | +0.57% | +12.31% | +16.61% | +40.13% | +102.12% |
| Pictet - Biotech - R EUR | EUR | Aktienfonds | - | 1'075.26 | -0.41% | +11.98% | +12.54% | +40.10% | +74.28% |
| PMG Helix Biotechnology Fund I-N USD | USD | Aktienfonds | - | 155.79 | +0.85% | +18.05% | +6.82% | +40.10% | - |
| Candriam Equities L Biotechnology, V2 - Capitalisation | USD | Aktienfonds | - | 3'056.14 | +0.61% | +16.50% | +18.55% | +39.60% | +91.38% |
| Pictet - Biotech - I dy GBP | GBP | Aktienfonds | - | 1'345.58 | -0.81% | +11.19% | +11.77% | +39.58% | +80.99% |
| PMG Helix Biotechnology Fund B USD | USD | Aktienfonds | - | 155.04 | +0.85% | +17.66% | +6.60% | +39.50% | - |
| Candriam Equities L Biotechnology, V - Capitalisation | USD | Aktienfonds | - | 3'361.76 | +0.61% | +16.61% | +18.68% | +39.29% | +87.39% |
| Candriam Equities L Biotechnology, R - Capitalisation | USD | Aktienfonds | - | 440.44 | +0.61% | +16.29% | +18.41% | +39.25% | +89.98% |
| Pictet - Biotech - Z USD | USD | Aktienfonds | - | 2'059.96 | -0.72% | +10.61% | +13.01% | +39.13% | +102.91% |
| Franklin Biotechnology Discovery Fund - N (acc) USD | USD | Aktienfonds | - | 54.18 | +0.56% | +11.67% | +16.17% | +39.07% | +97.59% |
| Candriam Equities L Biotechnology, I - Capitalisation | USD | Aktienfonds | - | 9'167.70 | +0.61% | +16.43% | +18.57% | +39.02% | +86.65% |
| JPMorgan Funds - Thematics - Genetic Therapies C (dist) - GBP | GBP | Aktienfonds | - | 82.90 | -0.18% | +20.57% | +21.73% | +38.88% | +31.78% |
| Franklin Biotechnology Discovery Fund - A (acc) SGD | SGD | Aktienfonds | - | 61.98 | +0.58% | +11.62% | +15.35% | +38.75% | +88.96% |
| Franklin Biotechnology Discovery Fund - F (acc) USD | USD | Aktienfonds | - | 20.57 | +0.59% | +11.49% | +16.02% | +38.71% | +96.09% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - GBP (hedged) | GBP | Aktienfonds | - | 136.20 | -0.05% | +20.04% | +22.83% | +38.65% | +43.20% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged) | GBP | Aktienfonds | - | 138.26 | -0.05% | +20.04% | +22.83% | +38.65% | +43.20% |
| Pictet - Biotech - P dy GBP | GBP | Aktienfonds | - | 1'092.80 | -0.81% | +10.46% | +11.28% | +38.34% | +76.22% |
| Franklin Biotechnology Discovery Fund - N (acc) PLN-H1 | PLN | Aktienfonds | - | 15.66 | +0.58% | +10.91% | +15.66% | +38.22% | +97.48% |
| Franklin Biotechnology Discovery Fund - I (acc) EUR-H1 | EUR | Aktienfonds | - | 39.01 | +0.57% | +11.08% | +15.79% | +38.14% | +94.95% |
| Candriam Equities L Biotechnology, C - Thesaurierung | USD | Aktienfonds | - | 1'358.18 | +0.60% | +15.53% | +17.88% | +38.03% | +85.00% |
| Candriam Equities L Biotechnology, C - Distribution | USD | Aktienfonds | - | 1'226.12 | +0.60% | +15.51% | +17.86% | +37.98% | +84.81% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - GBP (hedged) | GBP | Aktienfonds | - | 133.18 | -0.05% | +19.54% | +22.49% | +37.87% | +40.86% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - GBP (hedged) | GBP | Aktienfonds | - | 133.12 | -0.05% | +19.54% | +22.49% | +37.86% | +40.85% |
| Pictet - Biotech - I USD | USD | Aktienfonds | - | 1'783.68 | -0.72% | +9.80% | +12.45% | +37.76% | +96.95% |
| Candriam Equities L Biotechnology, N - Capitalisation | USD | Aktienfonds | - | 959.33 | +0.60% | +15.22% | +17.67% | +37.54% | +82.99% |
| Pictet - Biotech - HR dm ZAR | ZAR | Aktienfonds | - | 10'514.48 | -0.70% | +9.61% | +12.45% | +37.47% | +96.84% |
| JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - USD | USD | Aktienfonds | - | 100.70 | -0.10% | +19.19% | +22.57% | +37.27% | +44.00% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - USD | USD | Aktienfonds | - | 135.57 | -0.09% | +19.16% | +22.55% | +37.23% | +43.84% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - USD | USD | Aktienfonds | - | 137.50 | -0.09% | +19.16% | +22.55% | +37.23% | +43.84% |
| JPMorgan Funds - Thematics - Genetic Therapies C (dist) - USD | USD | Aktienfonds | - | 79.49 | -0.09% | +19.06% | +22.48% | +37.09% | +43.42% |
| JPMorgan Funds - Thematics - Genetic Therapies C (acc) - USD | USD | Aktienfonds | - | 111.28 | -0.10% | +19.05% | +22.47% | +37.08% | +43.44% |
| Franklin Biotechnology Discovery Fund - A (acc) EUR-H1 | EUR | Aktienfonds | - | 18.56 | +0.54% | +10.41% | +15.28% | +37.08% | +90.16% |
| Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares | EUR | Aktienfonds | - | 66.11 | +0.93% | +15.11% | +18.75% | +37.04% | +90.57% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - HKD (hedged) | HKD | Aktienfonds | - | 13.23 | -0.08% | +18.44% | +21.71% | +36.67% | +37.96% |
| Pictet - Biotech - P dy USD | USD | Aktienfonds | - | 1'449.45 | -0.73% | +9.07% | +11.95% | +36.54% | +91.75% |
| Pictet - Biotech - P USD | USD | Aktienfonds | - | 1'449.98 | -0.73% | +9.07% | +11.95% | +36.54% | +91.75% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - USD | USD | Aktienfonds | - | 133.02 | -0.10% | +18.68% | +22.23% | +36.50% | +41.69% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - USD | USD | Aktienfonds | - | 132.35 | -0.09% | +18.66% | +22.20% | +36.45% | +41.47% |
| JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - EUR (hedged) | EUR | Aktienfonds | - | 119.60 | -0.05% | +18.66% | +21.95% | +36.42% | +36.97% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - EUR (hedged) | EUR | Aktienfonds | - | 124.54 | -0.06% | +18.63% | +21.94% | +36.37% | +36.79% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - EUR (hedged) | EUR | Aktienfonds | - | 126.27 | -0.06% | +18.63% | +21.93% | +36.36% | +36.79% |
| Polar Capital Funds plc - Biotechnology Fund Class R EUR Distribution Shares | EUR | Aktienfonds | - | 62.41 | +0.92% | +14.66% | +18.45% | +36.36% | +88.15% |
| JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR (hedged) | EUR | Aktienfonds | - | 84.05 | -0.06% | +18.56% | +21.88% | +36.27% | +36.56% |
| Pictet - Biotech - HI CZK | CZK | Aktienfonds | - | 23'625.28 | -0.74% | +8.99% | +11.94% | +36.21% | - |
| JPMorgan Funds - Thematics - Genetic Therapies C (acc) - EUR (hedged) | EUR | Aktienfonds | - | 102.52 | -0.05% | +18.52% | +21.87% | +36.20% | +36.40% |
| Candriam Equities L Biotechnology, R-H - Capitalisation | EUR | Aktienfonds | - | 321.21 | +0.60% | +14.45% | +17.18% | +36.15% | +77.56% |
| Candriam Equities L Biotechnology, I-H - Capitalisation | EUR | Aktienfonds | - | 3'183.36 | +0.61% | +14.60% | +17.40% | +36.02% | +74.78% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - EUR (hedged) | EUR | Aktienfonds | - | 122.15 | -0.06% | +18.16% | +21.60% | +35.63% | +34.75% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - EUR (hedged) | EUR | Aktienfonds | - | 121.55 | -0.06% | +18.13% | +21.58% | +35.59% | +34.54% |
| Pictet - Biotech - R USD | USD | Aktienfonds | - | 1'222.07 | -0.74% | +8.50% | +11.56% | +35.58% | +87.73% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - SGD (hedged) | SGD | Aktienfonds | - | 13.19 | -0.08% | +17.77% | +21.34% | +35.28% | +35.42% |
| Franklin Biotechnology Discovery Fund - A (acc) JPY-H1 | JPY | Aktienfonds | - | 1'642.78 | +0.56% | +9.47% | +14.59% | +35.23% | - |
| JPMorgan Funds - Thematics - Genetic Therapies D (acc) - USD | USD | Aktienfonds | - | 88.90 | -0.11% | +17.78% | +21.60% | +35.09% | +37.28% |
| Galileo - Biotech Innovation Fund BC USD | USD | Aktienfonds | - | 71.22 | +0.24% | +23.35% | +28.37% | +35.04% | +44.11% |
| Candriam Equities L Biotechnology, C-H - Capitalisation | EUR | Aktienfonds | - | 302.04 | +0.60% | +13.73% | +16.69% | +35.01% | +73.16% |
| Pictet - Biotech - HP CZK | CZK | Aktienfonds | - | 21'493.83 | -0.75% | +8.27% | +11.44% | +35.00% | - |
| Pictet - Biotech - HR AUS | AUD | Aktienfonds | - | 1'150.49 | -0.73% | +8.27% | +11.55% | +34.88% | +79.73% |
| Pictet - Biotech - HI EUR | EUR | Aktienfonds | - | 919.83 | -0.75% | +8.15% | +11.34% | +34.87% | +84.09% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - SGD (hedged) | SGD | Aktienfonds | - | 12.69 | -0.08% | +17.28% | +20.97% | +34.57% | +33.02% |
| Candriam Equities L Biotechnology, N-H - Thesaurierung | EUR | Aktienfonds | - | 226.56 | +0.59% | +13.39% | +16.45% | +34.47% | - |
| Polar Capital Funds plc - Biotechnology Fund Class I GBP Distribution Shares | GBP | Aktienfonds | - | 56.70 | +0.55% | +13.06% | +17.25% | +34.46% | +88.75% |
| JPMorgan Funds - Thematics - Genetic Therapies D (acc) - EUR (hedged) | EUR | Aktienfonds | - | 95.73 | -0.06% | +17.29% | +21.01% | +34.28% | +30.74% |
| Galileo - Biotech Innovation Fund S USD | USD | Aktienfonds | - | 68.76 | +0.25% | +22.52% | +27.83% | +33.93% | +41.25% |
| Franklin Biotechnology Discovery Fund - F (acc) JPY-H1 | JPY | Aktienfonds | - | 1'614.81 | +0.56% | +8.56% | +13.94% | +33.82% | - |
| Franklin Biotechnology Discovery Fund - A (acc) CHF-H1 | CHF | Aktienfonds | - | 23.83 | +0.59% | +8.47% | +13.80% | +33.80% | +76.91% |
| Polar Capital Funds plc - Biotechnology Fund Class R GBP Distribution Shares | GBP | Aktienfonds | - | 53.53 | +0.56% | +12.65% | +16.95% | +33.79% | +86.32% |
| Pictet - Biotech - HP EUR | EUR | Aktienfonds | - | 836.85 | -0.75% | +7.43% | +10.84% | +33.68% | +79.23% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | CHF | Aktienfonds | - | 113.75 | -0.05% | +16.86% | +20.78% | +33.47% | +28.46% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) | CHF | Aktienfonds | - | 115.34 | -0.06% | +16.85% | +20.76% | +33.46% | +28.44% |
| JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) | CHF | Aktienfonds | - | 94.02 | -0.06% | +16.75% | +20.71% | +33.32% | +28.08% |
| Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | USD | Aktienfonds | - | 77.70 | +0.58% | +11.62% | +17.87% | +33.12% | +107.09% |
| Pictet - Biotech - HZ CHF | CHF | Aktienfonds | - | 1'530.32 | -0.78% | +7.01% | +10.49% | +33.05% | +76.94% |
| Galileo - Biotech Innovation Fund IM USD | USD | Aktienfonds | - | 150.88 | +0.23% | +21.84% | +27.35% | +32.98% | +38.42% |
| Candriam Equities L Biotechnology, R-H - Capitalisation | CHF | Aktienfonds | - | 296.92 | +0.60% | +12.32% | +15.61% | +32.81% | +65.28% |
| Polar Capital Funds plc - Biotechnology Fund Class I USD Distribution Shares | USD | Aktienfonds | - | 75.12 | +0.59% | +11.37% | +17.69% | +32.74% | +105.02% |
| Pictet - Biotech - HR EUR | EUR | Aktienfonds | - | 705.14 | -0.76% | +6.87% | +10.45% | +32.74% | +75.46% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | CHF | Aktienfonds | - | 111.03 | -0.06% | +16.36% | +20.42% | +32.71% | +26.33% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - CHF (hedged) | CHF | Aktienfonds | - | 111.10 | -0.07% | +16.35% | +20.42% | +32.70% | +26.32% |
| Protea Fund - Sectoral Biotech Opportunities Fund PF EUR | EUR | Aktienfonds | - | 12.02 | -0.58% | +9.87% | +10.07% | +32.23% | +39.93% |
| Polar Capital Funds plc - Biotechnology Fund Class I Hedged GBP Distribution Shares | GBP | Aktienfonds | - | 29.51 | +0.61% | +10.94% | +17.29% | +32.15% | +101.30% |
| Polar Capital Funds plc - Biotechnology Fund Class R USD Distribution Shares | USD | Aktienfonds | - | 70.92 | +0.58% | +10.95% | +17.40% | +32.12% | +102.40% |
| Pictet - Biotech - HP CHF | CHF | Aktienfonds | - | 936.88 | -0.79% | +5.53% | +9.46% | +30.57% | +67.22% |
| Protea Fund - Sectoral Biotech Opportunities Fund IF USD | USD | Aktienfonds | - | 13.59 | -0.37% | +7.35% | +8.98% | +30.30% | +54.96% |
| HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | USD | Aktienfonds | - | 676.36 | -0.18% | +6.71% | +11.76% | +30.01% | +75.35% |
| HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | USD | Aktienfonds | - | 650.22 | -0.18% | +6.33% | +11.48% | +29.15% | +72.27% |
| Protea Fund - Sectoral Biotech Opportunities Fund PF USD | USD | Aktienfonds | - | 12.21 | -0.33% | +6.64% | +8.53% | +29.07% | +50.55% |
| Bellevue Biotech DT CHF | CHF | Aktienfonds | - | 4'713.23 | +0.89% | +11.49% | +17.22% | +27.44% | +41.00% |
| Bellevue Biotech CA CHF | CHF | Aktienfonds | - | 134.40 | +0.89% | +11.24% | +17.04% | +27.07% | +39.80% |
| Bellevue Biotech AA CHF | CHF | Aktienfonds | - | 4'265.24 | +0.89% | +10.99% | +16.87% | +26.68% | +38.48% |
| Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF | CHF | Aktienfonds | - | 11.14 | -0.27% | +3.53% | +6.50% | +24.05% | - |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating | CHF | Aktienfonds | - | 146.78 | +0.56% | +9.59% | +17.52% | +22.16% | - |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | CHF | Aktienfonds | - | 469.54 | +0.56% | +9.48% | +17.43% | +21.99% | +6.41% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | CHF | Aktienfonds | - | 411.65 | +0.55% | +8.91% | +17.03% | +21.14% | +4.19% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating | EUR | Aktienfonds | - | 176.97 | +0.44% | +7.85% | +13.99% | +20.86% | +9.38% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating | EUR | Aktienfonds | - | 754.47 | +0.44% | +7.73% | +13.91% | +20.68% | +8.95% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating | EUR | Aktienfonds | - | 662.62 | +0.44% | +7.18% | +13.51% | +19.85% | +6.68% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | GBP | Aktienfonds | - | 510.62 | +0.07% | +5.83% | +12.46% | +18.42% | +7.91% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 USD - Accumulating | USD | Aktienfonds | - | 153.40 | +0.12% | +4.35% | +12.99% | +17.08% | - |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I USD - Accumulating | USD | Aktienfonds | - | 640.23 | +0.11% | +4.25% | +12.90% | +16.92% | +17.22% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions B USD - Accumulating | USD | Aktienfonds | - | 564.29 | +0.11% | +3.70% | +12.51% | +16.11% | +14.77% |
| CPR Invest - Biodiversity - IF2 EUR - Acc | EUR | Aktienfonds | - | 1'527.10 | -0.11% | +15.04% | +19.92% | +15.11% | - |
| MEDICAL BioInnovation Fund Class USD | USD | Aktienfonds | - | 223.22 | +0.69% | +2.51% | +15.86% | +14.34% | +64.02% |
| CPR Invest - Biodiversity - A EUR - Acc | EUR | Aktienfonds | - | 122.64 | -0.12% | +13.97% | +19.17% | +13.76% | - |
| CPR Invest - Biodiversity - IF1 EURH1 - Acc | EUR | Aktienfonds | - | 1'521.45 | -0.37% | +11.08% | +18.24% | +11.94% | - |
| CPR Invest - Biodiversity - IF2 EURH1 - Acc | EUR | Aktienfonds | - | 1'387.48 | -0.37% | +10.91% | +18.12% | +11.73% | - |
| Mirova Biodiversity Equity Z-NPF/A (EUR) | EUR | Aktienfonds | - | 104.74 | -0.05% | +4.58% | +6.27% | +4.79% | - |
| Mirova Biodiversity Equity R-NPF/A (EUR) | EUR | Aktienfonds | - | 97.79 | -0.06% | +3.09% | +5.25% | +2.80% | - |
| Candriam Equities L Biotechnology, I2 - Capitalisation | EUR | Aktienfonds | - | 1'728.63 | +0.94% | - | +15.37% | - | - |
| CPR Invest - Biodiversity - A USD - Acc | USD | Aktienfonds | - | 171.16 | -0.45% | +10.28% | +18.12% | - | - |
| CPR Invest - Biodiversity - F EUR - Acc | EUR | Aktienfonds | - | 133.02 | -0.13% | +13.11% | +18.59% | - | - |
| CPR Invest - Biodiversity - I EUR - Acc | EUR | Aktienfonds | - | 117.34 | -0.11% | +14.69% | +19.69% | - | - |
| CPR Invest - Biodiversity - U EUR - Acc | EUR | Aktienfonds | - | 148.08 | -0.12% | +13.33% | +18.74% | - | - |
| Polar Capital Funds plc - Biotechnology Fund Class R USD Accumulating Shares | USD | Aktienfonds | - | 10.70 | +0.56% | +10.77% | +17.20% | - | - |
| Janus Henderson Horizon Biotechnology Fund H2 EUR | EUR | Aktienfonds | - | 32.50 | +1.25% | - | +8.33% | - | - |